Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study

Neuroinflammation is emerging as an important pathological process in frontotemporal dementia (FTD), but biomarkers are lacking. We aimed to determine the value of complement proteins, which are key components of innate immunity, as biomarkers in cerebrospinal fluid (CSF) and plasma of presymptomati...

ver descrição completa

Detalhes bibliográficos
Autores: Ende, Emma L. van der, Heller, Carolin, Sogorb Esteve, Aitana, Swift, Imogen J., McFall, David, Peakman, Georgia, Bouzigues, Arabella, Poos, Jackie M., Jiskoot, Lize C., Panman, Jessica L., Papma, Janne M., Meeter, Lieke H., Dopper, Elise G. P., Bocchetta, Martina, Todd, Emily, Cash, David, Graff, Caroline, Synofzik, Matthis, Moreno, Fermin, Finger, Elizabeth, Sánchez Valle, Raquel, Vandenberghe, Rik, Laforce, Robert, Masellis, Mario, Tartaglia, Maria Carmela, Rowe, James B., Butler, Chris, Ducharme, Simon, Gerhard, Alexander, Danek, Adrian, Levin, Johannes, Pijnenburg, Yolande A. L., Otto, Markus, Borroni, Barbara, Tagliavini, Fabrizio, Mendonça, Alexandre de, Santana, Isabel, Galimberti, Daniela, Sorbi, Sandro, Zetterberg, Henrik
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2022
País:España
Recursos:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/206702
Acesso em linha:https://hdl.handle.net/2445/206702
Access Level:acceso abierto
Palavra-chave:Demència
Marcadors bioquímics
Dementia
Biochemical markers
id ES_8792f4ffa0765bc46e53eee39cfc4c03
oai_identifier_str oai:recercat.cat:2445/206702
network_acronym_str ES
network_name_str España
repository_id_str
spelling Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI studyEnde, Emma L. van derHeller, CarolinSogorb Esteve, AitanaSwift, Imogen J.McFall, DavidPeakman, GeorgiaBouzigues, ArabellaPoos, Jackie M.Jiskoot, Lize C.Panman, Jessica L.Papma, Janne M.Meeter, Lieke H.Dopper, Elise G. P.Bocchetta, MartinaTodd, EmilyCash, DavidGraff, CarolineSynofzik, MatthisMoreno, FerminFinger, ElizabethSánchez Valle, RaquelVandenberghe, RikLaforce, RobertMasellis, MarioTartaglia, Maria CarmelaRowe, James B.Butler, ChrisDucharme, SimonGerhard, AlexanderDanek, AdrianLevin, JohannesPijnenburg, Yolande A. L.Otto, MarkusBorroni, BarbaraTagliavini, FabrizioMendonça, Alexandre deSantana, IsabelGalimberti, DanielaSorbi, SandroZetterberg, HenrikDemènciaDemènciaMarcadors bioquímicsDementiaDementiaBiochemical markersNeuroinflammation is emerging as an important pathological process in frontotemporal dementia (FTD), but biomarkers are lacking. We aimed to determine the value of complement proteins, which are key components of innate immunity, as biomarkers in cerebrospinal fluid (CSF) and plasma of presymptomatic and symptomatic genetic FTD mutation carriers.We measured the complement proteins C1q and C3b in CSF by ELISAs in 224 presymptomatic and symptomatic GRN, C9orf72 or MAPT mutation carriers and non-carriers participating in the Genetic Frontotemporal Dementia Initiative (GENFI), a multicentre cohort study. Next, we used multiplex immunoassays to measure a panel of 14 complement proteins in plasma of 431 GENFI participants. We correlated complement protein levels with corresponding clinical and neuroimaging data, neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP).CSF C1q and C3b, as well as plasma C2 and C3, were elevated in symptomatic mutation carriers compared to presymptomatic carriers and non-carriers. In genetic subgroup analyses, these differences remained statistically significant for C9orf72 mutation carriers. In presymptomatic carriers, several complement proteins correlated negatively with grey matter volume of FTD-related regions and positively with NfL and GFAP. In symptomatic carriers, correlations were additionally observed with disease duration and with Mini Mental State Examination and Clinical Dementia Rating scale® plus NACC Frontotemporal lobar degeneration sum of boxes scores.Elevated levels of CSF C1q and C3b, as well as plasma C2 and C3, demonstrate the presence of complement activation in the symptomatic stage of genetic FTD. Intriguingly, correlations with several disease measures in presymptomatic carriers suggest that complement protein levels might increase before symptom onset. Although the overlap between groups precludes their use as diagnostic markers, further research is needed to determine their potential to monitor dysregulation of the complement system in FTD.© 2022. The Author(s).Springer Nature2024202420222023info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://hdl.handle.net/2445/206702Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésReproducció del document publicat a: https://doi.org/10.1186/s12974-022-02573-0Journal Of Neuroinflammation, 2022, vol. 19, num. 1https://doi.org/10.1186/s12974-022-02573-0cc by (c) Ende, E. L. van der et al., 2022http://creativecommons.org/licenses/by/3.0/es/info:eu-repo/semantics/openAccessoai:recercat.cat:2445/2067022026-05-29T05:05:01Z
dc.title.none.fl_str_mv Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study
title Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study
spellingShingle Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study
Ende, Emma L. van der
Demència
Demència
Marcadors bioquímics
Dementia
Dementia
Biochemical markers
title_short Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study
title_full Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study
title_fullStr Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study
title_full_unstemmed Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study
title_sort Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study
dc.creator.none.fl_str_mv Ende, Emma L. van der
Heller, Carolin
Sogorb Esteve, Aitana
Swift, Imogen J.
McFall, David
Peakman, Georgia
Bouzigues, Arabella
Poos, Jackie M.
Jiskoot, Lize C.
Panman, Jessica L.
Papma, Janne M.
Meeter, Lieke H.
Dopper, Elise G. P.
Bocchetta, Martina
Todd, Emily
Cash, David
Graff, Caroline
Synofzik, Matthis
Moreno, Fermin
Finger, Elizabeth
Sánchez Valle, Raquel
Vandenberghe, Rik
Laforce, Robert
Masellis, Mario
Tartaglia, Maria Carmela
Rowe, James B.
Butler, Chris
Ducharme, Simon
Gerhard, Alexander
Danek, Adrian
Levin, Johannes
Pijnenburg, Yolande A. L.
Otto, Markus
Borroni, Barbara
Tagliavini, Fabrizio
Mendonça, Alexandre de
Santana, Isabel
Galimberti, Daniela
Sorbi, Sandro
Zetterberg, Henrik
author Ende, Emma L. van der
author_facet Ende, Emma L. van der
Heller, Carolin
Sogorb Esteve, Aitana
Swift, Imogen J.
McFall, David
Peakman, Georgia
Bouzigues, Arabella
Poos, Jackie M.
Jiskoot, Lize C.
Panman, Jessica L.
Papma, Janne M.
Meeter, Lieke H.
Dopper, Elise G. P.
Bocchetta, Martina
Todd, Emily
Cash, David
Graff, Caroline
Synofzik, Matthis
Moreno, Fermin
Finger, Elizabeth
Sánchez Valle, Raquel
Vandenberghe, Rik
Laforce, Robert
Masellis, Mario
Tartaglia, Maria Carmela
Rowe, James B.
Butler, Chris
Ducharme, Simon
Gerhard, Alexander
Danek, Adrian
Levin, Johannes
Pijnenburg, Yolande A. L.
Otto, Markus
Borroni, Barbara
Tagliavini, Fabrizio
Mendonça, Alexandre de
Santana, Isabel
Galimberti, Daniela
Sorbi, Sandro
Zetterberg, Henrik
author_role author
author2 Heller, Carolin
Sogorb Esteve, Aitana
Swift, Imogen J.
McFall, David
Peakman, Georgia
Bouzigues, Arabella
Poos, Jackie M.
Jiskoot, Lize C.
Panman, Jessica L.
Papma, Janne M.
Meeter, Lieke H.
Dopper, Elise G. P.
Bocchetta, Martina
Todd, Emily
Cash, David
Graff, Caroline
Synofzik, Matthis
Moreno, Fermin
Finger, Elizabeth
Sánchez Valle, Raquel
Vandenberghe, Rik
Laforce, Robert
Masellis, Mario
Tartaglia, Maria Carmela
Rowe, James B.
Butler, Chris
Ducharme, Simon
Gerhard, Alexander
Danek, Adrian
Levin, Johannes
Pijnenburg, Yolande A. L.
Otto, Markus
Borroni, Barbara
Tagliavini, Fabrizio
Mendonça, Alexandre de
Santana, Isabel
Galimberti, Daniela
Sorbi, Sandro
Zetterberg, Henrik
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Demència
Demència
Marcadors bioquímics
Dementia
Dementia
Biochemical markers
topic Demència
Demència
Marcadors bioquímics
Dementia
Dementia
Biochemical markers
description Neuroinflammation is emerging as an important pathological process in frontotemporal dementia (FTD), but biomarkers are lacking. We aimed to determine the value of complement proteins, which are key components of innate immunity, as biomarkers in cerebrospinal fluid (CSF) and plasma of presymptomatic and symptomatic genetic FTD mutation carriers.We measured the complement proteins C1q and C3b in CSF by ELISAs in 224 presymptomatic and symptomatic GRN, C9orf72 or MAPT mutation carriers and non-carriers participating in the Genetic Frontotemporal Dementia Initiative (GENFI), a multicentre cohort study. Next, we used multiplex immunoassays to measure a panel of 14 complement proteins in plasma of 431 GENFI participants. We correlated complement protein levels with corresponding clinical and neuroimaging data, neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP).CSF C1q and C3b, as well as plasma C2 and C3, were elevated in symptomatic mutation carriers compared to presymptomatic carriers and non-carriers. In genetic subgroup analyses, these differences remained statistically significant for C9orf72 mutation carriers. In presymptomatic carriers, several complement proteins correlated negatively with grey matter volume of FTD-related regions and positively with NfL and GFAP. In symptomatic carriers, correlations were additionally observed with disease duration and with Mini Mental State Examination and Clinical Dementia Rating scale® plus NACC Frontotemporal lobar degeneration sum of boxes scores.Elevated levels of CSF C1q and C3b, as well as plasma C2 and C3, demonstrate the presence of complement activation in the symptomatic stage of genetic FTD. Intriguingly, correlations with several disease measures in presymptomatic carriers suggest that complement protein levels might increase before symptom onset. Although the overlap between groups precludes their use as diagnostic markers, further research is needed to determine their potential to monitor dysregulation of the complement system in FTD.© 2022. The Author(s).
publishDate 2022
dc.date.none.fl_str_mv 2022
2023
2024
2024
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/206702
url https://hdl.handle.net/2445/206702
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Reproducció del document publicat a: https://doi.org/10.1186/s12974-022-02573-0
Journal Of Neuroinflammation, 2022, vol. 19, num. 1
https://doi.org/10.1186/s12974-022-02573-0
dc.rights.none.fl_str_mv cc by (c) Ende, E. L. van der et al., 2022
http://creativecommons.org/licenses/by/3.0/es/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv cc by (c) Ende, E. L. van der et al., 2022
http://creativecommons.org/licenses/by/3.0/es/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Springer Nature
publisher.none.fl_str_mv Springer Nature
dc.source.none.fl_str_mv Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869412471670833152
score 15,81155